Dr. Matt Thompson is the President and Chief Executive Officer (CEO) of Endologix LLC. Prior to his CEO appointment in November 2021, he served as the company’s Chief Medical Officer (CMO) from 2016, overseeing business development, medical affairs, regulatory, clinical, and R&D departments. Among his notable contributions as CMO was to lead the  acquisition and integration of PQ Bypass in April 2021.

Previously he was the Professor of Vascular Surgery at St George’s, University of London and Staff Surgeon in the Department of Vascular Surgery at the Heart, Vascular and Thoracic Institute, Cleveland Clinic Foundation, Ohio. Dr. Thompson trained at Cambridge, St Bartholomew’s Hospital, the University of Leicester and Adelaide. He studied corporate innovation at Stanford University, Graduate School of Business. His awards include a Hunterian Professorship, the Moynihan travelling fellowship and the gold medal for the intercollegiate examination. His named lectures include the Kinmonth Lecture (Vascular Society Great Britain and Ireland), the British Journal of Surgery Lecture (Vascular Society Great Britain and Ireland), and the Chee Song Memorial Lecture (British Society of Endovascular Therapy). He has published over 400 peer reviewed articles.

His clinical interests were in the treatment of aortic disease and endovascular surgery. His research interests include health service outcome research, clinical trials, and translational investigations into aortic disease. Dr. Thompson is the editor of the Oxford Textbook of Vascular Surgery and the Oxford Handbook of Vascular Surgery. He has been the clinical director for three London-wide service reconfigurations (cardiovascular disease, major trauma, and emergency services). He was Chair of the National Specialized Commissioning Clinical Reference Group for Vascular Services. He is a founder of the British Society for Endovascular Therapy, a past Council Member of the Vascular Society, was Chairman of the Vascular Society Annual Scientific Meeting and was awarded a Lifetime Achievement Award by the Vascular Society of Great Britain and Ireland in 2017.

Cindy Pinto was appointed as the Chief Financial Officer in March 2021 after serving as the Interim CFO and principal financial officer since June 2020. During her tenure, she has held various positions in the Finance Department, most recently she was the Vice President, Financial Planning and Analysis. Prior to that, Cindy served as the Company’s Senior Finance Director from February 2016 through September 2018 and as Finance Director from September 2014 through January 2016. Prior to joining Endologix, Cindy served as Finance Director at Covidien. She received a BS in Accounting from Villanova University and an MBA from New York University. During her free time Cindy enjoys hiking, traveling and spending time with her family.

Mike joined Endologix as the Chief Commercial Officer in March 2024. Mike Mathias has spent his thirty-year career successfully leading commercial organizations in the cardiovascular space. Most recently, he played a seminal role as Vice President, Commercial Operations at LimFlow, Inc. which Inari Medical acquired. As the LimFlow, Inc., commercial leader, he led the development and execution of the LimFlow System’s U.S. commercial launch. Prior to joining LimFlow, Inc., he spent 20 years in various commercial leadership roles at Medtronic. He led Medtronic’s $1.2 billion Heart Valve Therapies U.S commercial operations, launching TAVR (Transcatheter Aortic Valve Replacement). Prior to leading the Heart Valve Therapies commercial organization, he held sales management roles across Medtronic’s cardiology, endovascular, cardiac surgery, peripheral, perfusion, and cardiac rhythm businesses, as well as a variety of sales roles in the cardiology franchise for Pfizer. He earned a B.S. in Arabic and French Studies at the U.S. Military Academy at West Point and holds a master’s degree in business administration from the University of Minnesota.

Beth joined Endologix as the Chief Operating Officer in September 2022. She is currently a Managing Partner and the co-founder of Sequoia Ventures, a provider of investment capital and strategic leadership to growing middle-market businesses. In 2008 she co-founded VFD Technologies, Inc., a precision medical device and robotics manufacturing company, where she served on the board of directors and for thirteen years served as the President and Chief Commercial Officer for the four manufacturing entities. Acquired by Arch Global Precision in 2021, the company now operates as Arch Medical Solutions. Prior to VFD, Beth served as Vice President of Operations and Quality of Kyphon Inc., a NASDAQ-listed global medical device company focused on minimally invasive spinal therapies, from 2002 through its acquisition by Medtronic, Inc. in late 2007 and with Medtronic through 2008. Prior to Kyphon, Beth served as a Board of Director Member and Vice President for Intercon, Inc. a contract manufacturing firm specializing in fiber and electrical assemblies for a variety of markets. Ms. Rothwell holds a M.S. in Biomedical Engineering from Virginia Polytechnic Institute and a B.S. in Ceramic Engineering from Alfred University. She is also a graduate of the Harvard Business School’s Women in Leadership Program.

Elisa Hebb joined Endologix in August 2018 with more than twenty years of success in Clinical Research and Regulatory Affairs. She has led the development and execution of global clinical studies for both Class II and Class III medical devices in addition to leading regulatory strategies, and submissions for US and international agencies. Elisa comes to us from Spirox/Stryker where she was responsible for Clinical and Regulatory Affairs and was the Compliance Officer.  Previously, Elisa was the Senior Director of Global Clinical Affairs and Clinical Development for Philips Volcano.  Prior vice presidential roles held by Elisa include Atheromed, Crux Biomedical and Apneon. Prior experience is largely in vascular and electrophysiology with such companies as Boston Scientific, Vascular Architects and ACS/Guidant. Elisa earned her Bachelor’s degree from UC Berkeley. She especially enjoys her family, friends, gardening and the fiber arts.